Significant Long-term Efficacy of Zigakibart for IgA Nephropathy During ERA Congress The latest findings from the 62nd ERA Congress highlight the sustained effectiveness and safety of zigakibart in treating IgA nephropathy, potentially transforming patient care.

Significant Long-term Efficacy of Zigakibart for IgA Nephropathy During ERA Congress #USA #Vienna #IgA_nephropathy #ERA_Congress #zigakibart

ERA Congress Highlights Promising Long-Term Efficacy of Zigakibart in IgA Nephropathy Treatment At the recent ERA Congress, new data on zigakibart revealed its long-term efficacy and safety in treating IgA nephropathy. These findings offer hope for improved patient outcomes.

ERA Congress Highlights Promising Long-Term Efficacy of Zigakibart in IgA Nephropathy Treatment #None #IgA_nephropathy #ERA_Congress #zigakibart

Fresenius Medical Care Unveils Innovative Research for Kidney Care at ERA 2025 Discover Fresenius Medical Care's groundbreaking research for kidney care presented at ERA 2025, showcasing AI advancements and improved patient outcomes.

Fresenius Medical Care Unveils Innovative Research for Kidney Care at ERA 2025 #Germany #Kidney_Care #Bad_Homburg #Fresenius_Medical #ERA_Congress